Before discharge | P value (− vs +) | 1 Year after | P value (− vs +) | |||
Event (−) | Event (+) | Event (−) | Event (+) | |||
N=299 | N=144 | N=140 | N=31 | |||
Age, years | 81±9 | 84±8 | <0.001 | 81±8 | 83±8 | 0.257 |
Male sex, n (%) | 117 (39) | 55 (38) | 0.466 | 55 (39) | 12 (39) | 0.557 |
Systolic blood pressure, mm Hg | 117±17 | 119±18 | 0.261 | 128±23 | 122±20 | 0.273 |
Diastolic blood pressure, mm Hg | 65±12 | 64±11 | 0.466 | 65±11 | 64±8 | 0.654 |
Heart rate, bpm | 71±13 | 72±13 | 0.414 | 69±15 | 71±15 | 0.597 |
Atrial fibrillation, n (%) | 130 (43) | 61 (42) | 0.452 | 58 (41) | 16 (52) | 0.201 |
Coronary artery disease, n (%) | 60 (20) | 30 (21) | 0.475 | 31 (22) | 6 (19) | 0.460 |
Diabetes mellitus, n (%) | 103 (34) | 56 (39) | 0.209 | 57 (41) | 8 (26) | 0.089 |
Dyslipidaemia, n (%) | 127 (42) | 55 (38) | 0.227 | 69 (49) | 10 (32) | 0.064 |
Hypertension, n (%) | 262 (88) | 127 (88) | 0.493 | 127 (91) | 24 (77) | 0.037 |
Echocardiographic data | ||||||
LAD, mm | 44±7 | 45±8 | 0.269 | 44±8 | 47±7 | 0.199 |
LAVI, mL/m2 | 53±23 | 59±25 | 0.025 | 51±23 | 62±26 | 0.043 |
SV, mL | 49±20 | 49±19 | 0.862 | 48±18 | 40±19 | 0.096 |
LVESV, mL | 31±16 | 32±16 | 0.713 | 28±12 | 33±14 | 0.104 |
LVEDV, mL | 80±34 | 81±33 | 0.814 | 75±27 | 78±24 | 0.726 |
LVEF, % | 61±7 | 61±8 | 0.252 | 63±7 | 57±10 | 0.001 |
LVMI, g/m2 | 106±32 | 110±37 | 0.227 | 100±28 | 118±36 | 0.006 |
E, m/s | 0.91±0.30 | 0.97±0.29 | 0.036 | 0.95±0.29 | 0.92±0.30 | 0.621 |
mean e′, cm/s | 6.0±1.9 | 6.1±1.8 | 0.575 | 5.9±1.6 | 5.8±1.7 | 0.730 |
DcT, s | 0.21±0.07 | 0.23±0.08 | 0.131 | 0.23±0.08 | 0.21±0.06 | 0.422 |
All-cause mortality and/or re-admission for heart failure was evaluated for 2 years. Values are mean±SD or number (%).
DcT, deceleration time of E wave; LAD, left atrial diameter; LAV, left atrial volume; LAVI, left atrial volume index; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVESV, left ventricular end-systolic volume; LVMI, left ventricular mass index; SV, stroke volume.